S
Seyed Mohammad Gheibi Hayat
Researcher at Shahid Sadoughi University of Medical Sciences and Health Services
Publications - 49
Citations - 1201
Seyed Mohammad Gheibi Hayat is an academic researcher from Shahid Sadoughi University of Medical Sciences and Health Services. The author has contributed to research in topics: Immune system & Efferocytosis. The author has an hindex of 16, co-authored 48 publications receiving 616 citations. Previous affiliations of Seyed Mohammad Gheibi Hayat include Mashhad University of Medical Sciences.
Papers
More filters
Journal ArticleDOI
COVID-19 and cardiac injury: clinical manifestations, biomarkers, mechanisms, diagnosis, treatment, and follow up.
Amir Tajbakhsh,Seyed Mohammad Gheibi Hayat,Hajar Taghizadeh,Ali Akbari,Masoumeh Inabadi,Amir Savardashtaki,Thomas P. Johnston,Amirhossein Sahebkar,Amirhossein Sahebkar +8 more
TL;DR: It is suggested that heart injury caused by CO VID-19 infection might be an important cause of severe clinical phenotypes or adverse events in affected patients, and early measurements of cardiac damage via biomarkers following hospitalization for COVID-19 infections in a patient with preexisting CVD are recommended.
Journal ArticleDOI
CD47: role in the immune system and application to cancer therapy.
Seyed Mohammad Gheibi Hayat,Vanessa Bianconi,Matteo Pirro,Mahmoud Reza Jaafari,Mahdi Hatamipour,Amirhossein Sahebkar +5 more
TL;DR: The most advanced approach is the use of anti-CD47 antibodies, which enhances cancer cell phagocytosis via inhibition of the CD47-SIRPα axis, which can achieve higher anti-cancer efficacies when combined with chemotherapy and immunotherapy and hold promise for improving the survival of patients with cancer.
Journal ArticleDOI
Atherosclerosis and immunity: A perspective.
Fereshte Abdolmaleki,Seyed Mohammad Gheibi Hayat,Vanessa Bianconi,Thomas P. Johnston,Amirhossein Sahebkar +4 more
TL;DR: The pathophysiology of atherosclerotic disease as it relates to the contribution from the immune system is summarized, reviewing the crucial role of macrophages, T and B lymphocytes.
Journal ArticleDOI
Nanovaccine: A novel approach in immunization.
TL;DR: Benefits of the nanovaccines include their better stability in blood flow to increase the shelf life in blood, enhanced immune system stimulation,No need for booster doses, no need to maintain the cold chain, and ability to create active targeting.
Journal ArticleDOI
The Role of Efferocytosis in Autoimmune Diseases.
Fereshte Abdolmaleki,Najmeh Farahani,Seyed Mohammad Gheibi Hayat,Matteo Pirro,Vanessa Bianconi,George E. Barreto,George E. Barreto,Amirhossein Sahebkar +7 more
TL;DR: The apoptosis pathways and their immune regulation were reviewed, and efferocytosis process and its impairment in association with some autoimmune diseases were discussed.